MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings P/E Ratio 2011-2026 | ONVO
Annual P/E Ratio Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.25 | -0.0509 | -0.495 | -1.23 | -2.91 | -4.33 | -3.82 | -7.37 | -6.51 | -12 | -16.5 | -337 | -4.23 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0509 | -337 | -30.6 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
34.7 | $ 110.28 | -2.82 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
61 | $ 13.21 | -2.44 % | $ 3.75 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | USA |
|
Biodesix
BDSX
|
-2.14 | $ 14.31 | -2.02 % | $ 1.86 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M |  Britain |
 |
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 16.41 | -11.3 % | $ 177 M |  China |
 |
BioNano Genomics
BNGO
|
-0.301 | $ 1.15 | -0.43 % | $ 6.26 M | USA |
 |
Bioventus
BVS
|
26.7 | $ 9.03 | -2.48 % | $ 602 M | USA |
 |
Co-Diagnostics
CODX
|
-0.988 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
30.5 | $ 62.84 | -4.93 % | $ 24.5 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | USA |
 |
Fulgent Genetics
FLGT
|
-10.9 | $ 15.54 | -5.13 % | $ 470 M | USA |
 |
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
-32.3 | $ 84.0 | -4.65 % | $ 10.5 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
38.9 | $ 24.0 | -2.83 % | $ 667 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
-53.3 | $ 158.89 | -3.78 % | $ 7.88 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 195.64 | -1.27 % | $ 21.7 B | USA |
 |
OpGen
OPGN
|
0.761 | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
-0.787 | $ 8.45 | - | $ 33.7 M | Israel |
 |
ICON Public Limited Company
ICLR
|
21 | $ 102.3 | -0.76 % | $ 8.44 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
48.3 | $ 561.97 | -1.98 % | $ 45.2 B | USA |
 |
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
-13.4 | $ 117.62 | -5.45 % | $ 18.7 B | USA |
 |
PerkinElmer
PKI
|
52.3 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
0.615 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Medpace Holdings
MEDP
|
28.7 | $ 452.91 | -2.94 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
32.7 | $ 1 233.1 | -2.91 % | $ 25.4 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-1.12 | $ 4.38 | -5.19 % | $ 406 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-0.191 | $ 4.26 | -7.19 % | $ 2.29 M | USA |
 |
NeoGenomics
NEO
|
-13.7 | $ 7.35 | -5.28 % | $ 942 M | USA |
 |
IQVIA Holdings
IQV
|
20.8 | $ 164.54 | -2.87 % | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | Israel |
 |
National Research Corporation
NRC
|
27.2 | $ 17.2 | -0.95 % | $ 385 M | USA |
 |
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
-9.69 | $ 184.45 | -5.96 % | $ 18.2 B | USA |
 |
OPKO Health
OPK
|
86.6 | $ 1.15 | -1.79 % | $ 798 M | USA |